Trent share price today, February 05: Trent shares drop 17% in a month; experts see long-term upside. Explore investment strategies…
Is it a good Budget or a band-aid Budget? Market gurus highlight the key aspects of the Budget and what…
A fine balance or a big boost to spending, call it by any name but the Budget for FY26 is…
The Budget is all about boosting consumption and reviving demand. The FM has walked the tight rope balancing consumption and…
The share market has its wishlist ready for the Finance Minister. Tweak in tax rates and boost for the common…
Nilesh Shah of Kotak AMC, in an exclusive to Finacial Express.com, highlights the key concerns for markets now and expectation…
What’s worrying FII investors the most, is it Trump’s new Tariff or dollar’s weakness? A detailed analysis of the top…
UBS Securities believes that the Indian economy has the potential to be $6 trillion economy by 2030 but the journey…
Nuvama downgrades VIP Industries to ‘Reduce’ due to slow margins. Check its revised target and challenges faced now!
Morgan Stanley’s Ridham Desai urges buying on dips, forecasting growth return and improved market sentiment.
Explore ITC Hotels’ journey as an independent entity with strong expansion plans and strategic growth enablers. Learn more now!
Analysts predict ITC Hotels’ shares to list between Rs 120-175 as it debuts today. Keep track of the market dynamics…
DLF’s Q3FY25 pre-sales soar on the ‘Dahlias’ project launch. Nuvama maintains Buy with target at Rs 1,040. Explore more about…
Small cap stocks slump due to weak earnings, muted sentiment, high valuations, and FII outflows. Dive into key insights now!
RBI infused liquidity worth over Rs 1.5 trillion. Find out what this means for the banking sector and why the…
Discover the top 5 BSE 500 stock losers in 2025 and see if your portfolio is affected. Stay informed and…
Nuvama lists out 4 reasons why they have rated MphasiS Buy. However they have a revised the price target lower.…
The mid and small cap stocks are seeing significant selling with maximum losses in pharma and financials.
